Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ABCN NYSEARCA:EMC TSE:FRX TSE:PLI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCNVIVO CannabisC$1.32+5.6%C$1.32C$0.80▼C$4.06C$256.62MN/A1.51 million shs310,601 shsEMCGlobal X Emerging Markets Great Consumer ETF$35.90+2.4%$32.76$26.73▼$36.02$63.54M0.8214,726 shs4,370 shsFRXFennec PharmaceuticalsC$8.87C$9.68C$7.59▼C$13.83C$307.90M3.2180741,110 shs111 shsPLIProMetic Life SciencesC$0.00C$7.13▼C$590.00C$317.06MN/A8,002 shs921 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABCNVIVO Cannabis0.00%0.00%0.00%0.00%0.00%EMCGlobal X Emerging Markets Great Consumer ETF0.00%+0.86%+13.55%+5.42%+29.35%FRXFennec Pharmaceuticals0.00%-5.64%-0.67%-13.12%+3.74%PLIProMetic Life Sciences0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCNVIVO CannabisC$1.32+5.6%C$1.32C$0.80▼C$4.06C$256.62MN/A1.51 million shs310,601 shsEMCGlobal X Emerging Markets Great Consumer ETF$35.90+2.4%$32.76$26.73▼$36.02$63.54M0.8214,726 shs4,370 shsFRXFennec PharmaceuticalsC$8.87C$9.68C$7.59▼C$13.83C$307.90M3.2180741,110 shs111 shsPLIProMetic Life SciencesC$0.00C$7.13▼C$590.00C$317.06MN/A8,002 shs921 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABCNVIVO Cannabis0.00%0.00%0.00%0.00%0.00%EMCGlobal X Emerging Markets Great Consumer ETF0.00%+0.86%+13.55%+5.42%+29.35%FRXFennec Pharmaceuticals0.00%-5.64%-0.67%-13.12%+3.74%PLIProMetic Life Sciences0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABCNVIVO Cannabis 0.00N/AN/AN/AEMCGlobal X Emerging Markets Great Consumer ETF 2.74Moderate Buy$35.90N/AFRXFennec Pharmaceuticals 4.00Strong BuyN/AN/APLIProMetic Life Sciences 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ABCN, FRX, PLI, and EMC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/11/2026FRXFennec Pharmaceuticals B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABCNVIVO CannabisN/AN/AN/AN/AN/AN/AEMCGlobal X Emerging Markets Great Consumer ETFN/AN/AN/AN/AN/AN/AFRXFennec PharmaceuticalsC$44.64M6.90C$0.76 per share11.66C$1.12 per share7.89PLIProMetic Life SciencesC$39.91M0.00N/A3.94C$6.07 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABCNVIVO CannabisN/AN/AN/AN/AN/AN/AN/AN/AN/AEMCGlobal X Emerging Markets Great Consumer ETFN/A$1.0733.55N/AN/AN/AN/AN/AN/AFRXFennec Pharmaceuticals-C$800.44K-C$0.34N/AN/AN/A-22.69%-236.42%8.88%N/APLIProMetic Life SciencesN/A-C$63.06N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABCNVIVO CannabisN/AN/AN/AN/AN/AEMCGlobal X Emerging Markets Great Consumer ETF$0.240.67%N/A22.43%N/AFRXFennec PharmaceuticalsN/A2.02%N/AN/AN/APLIProMetic Life SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABCNVIVO CannabisN/AN/AN/AEMCGlobal X Emerging Markets Great Consumer ETFN/AN/AN/AFRXFennec PharmaceuticalsN/A6.3410.17PLIProMetic Life Sciences37.474.063.66Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABCNVIVO CannabisN/AEMCGlobal X Emerging Markets Great Consumer ETF79.86%FRXFennec Pharmaceuticals12.35%PLIProMetic Life SciencesN/AInsider OwnershipCompanyInsider OwnershipABCNVIVO CannabisN/AEMCGlobal X Emerging Markets Great Consumer ETF0.40%FRXFennec Pharmaceuticals16.20%PLIProMetic Life SciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABCNVIVO CannabisN/A194.41 millionN/ANot OptionableEMCGlobal X Emerging Markets Great Consumer ETFN/A1.77 millionN/ANot OptionableFRXFennec Pharmaceuticals1034.71 millionN/ANot OptionablePLIProMetic Life Sciences48723.31 millionN/ANot OptionableABCN, FRX, PLI, and EMC HeadlinesRecent News About These CompaniesNew PLI Treatise Helps Practitioners Navigate the Complexities of Trade Secret LawOctober 3, 2024 | ipwatchdog.comIRethinking rare diseases: treat the whole patientAugust 29, 2024 | pharmaphorum.comPPanetta Institute for Public PolicyMarch 31, 2024 | scu.eduS2024 Breakthrough Prizes in Life SciencesOctober 11, 2023 | the-scientist.comTTMC Life Sciences Bhd (TMCN)July 24, 2023 | investing.comLife Sciences Learning CommunityJune 13, 2023 | slu.eduSChicago Life Sciences SummitApril 21, 2023 | bisnow.comBCollege of Liberal Arts & SciencesApril 10, 2023 | alfred.eduALabviva nets $20M Series A to ease life science procurement processMarch 27, 2023 | endpts.comETrends that will shape the life sciences industry in 2023 and beyondFebruary 24, 2023 | hindustantimes.comHPharma sector gets first tranche of payment under under PLI schemeFebruary 24, 2023 | moneycontrol.comArithmos appoints Maurizio Giraudo as Managing Director of the new Life Sciences Business Consulting UnitFebruary 21, 2023 | finance.yahoo.comWEF, Telangana joins hands to start thematic centre on healthcare and life sciencesJanuary 18, 2023 | health.economictimes.indiatimes.comWorking on PLI schemes for more sectors: Piyush GoyalSeptember 24, 2022 | retail.economictimes.indiatimes.comTSX:CVE (CENOVUS ENERGY INC.)July 30, 2021 | fool.caMedia Sentiment Over Time Top HeadlinesView All HeadlinesGPU Prices Are Surging—3 Ways to Play the AI Chip ShortageBy Thomas Hughes | April 14, 2026These are the 3 Biggest AI Winners and Losers of 2026By Leo Miller | April 13, 2026Verizon’s Signal Strength: The Turnaround Call Is Loud and ClearBy Jeffrey Neal Johnson | April 30, 2026These 3 ETFs Are Suitable for Ultra-Bearish InvestorsBy Nathan Reiff | April 11, 20262 Stocks to Watch as the Quantum Space Gets More CrowdedBy Nathan Reiff | May 3, 2026ABCN, FRX, PLI, and EMC Company DescriptionsVIVO Cannabis CVE:ABCNC$1.32 +0.07 (+5.60%) As of 08/3/2018ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.Global X Emerging Markets Great Consumer ETF NYSEARCA:EMC$35.90 +0.84 (+2.40%) As of 04:10 PM EasternThe Global X Emerging Markets Great Consumer ETF (EMC) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that invests in companies across multiple sectors that are positioned to benefit from the increasing consumption and growing purchasing power of consumers from the emerging markets. EMC was launched on Sep 24, 2010 and is managed by Global X.Fennec Pharmaceuticals TSE:FRXC$8.87 0.00 (0.00%) As of 05/4/2026 05:00 PM EasternFennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.ProMetic Life Sciences TSE:PLIPrometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
